Literature DB >> 6723786

In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites.

J Benavides, F Guilloux, P Rufat, A Uzan, C Renault, M C Dubroeucq, C Gueremy, G Le Fur.   

Abstract

'Peripheral type' benzodiazepine binding sites in several rat tissues were labelled by intravenous injection of [3H]PK 11195 and [3H] RO5 -4864. Binding was saturable in all tissues studied and regional distribution paralleled the in vitro binding. A similar potency order of displacing compounds was found in vivo and in vitro PK 11195 greater than PK 11211 greater than RO5 -4864 greater than diazepam greater than dipyridamole greater than clonazepam. These results demonstrate the feasibility of using this technique to examine the effects of pharmacological manipulation on the binding sites in their native state. However some properties (broader maximum during time course, higher percentage of particulate binding in the brain and independence of temperature) make [3H]PK 11195 the most suitable ligand for this kind of studies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723786     DOI: 10.1016/0014-2999(84)90425-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Role of cortical spreading depression in the pathophysiology of migraine.

Authors:  Yilong Cui; Yosky Kataoka; Yasuyoshi Watanabe
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

2.  Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography.

Authors:  K Hashimoto; O Inoue; K Suzuki; T Yamasaki; M Kojima
Journal:  Ann Nucl Med       Date:  1989-07       Impact factor: 2.668

3.  Benzodiazepine receptors: multiple receptors or multiple conformations?

Authors:  W Sieghart
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  [18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats.

Authors:  Hervé Boutin; Christian Prenant; Renaud Maroy; James Galea; Andrew D Greenhalgh; Alison Smigova; Christopher Cawthorne; Peter Julyan; Shane M Wilkinson; Samuel D Banister; Gavin Brown; Karl Herholz; Michael Kassiou; Nancy J Rothwell
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

5.  An alteration in the lateral geniculate nucleus of experimental glaucoma monkeys: in vivo positron emission tomography imaging of glial activation.

Authors:  Masamitsu Shimazawa; Yasushi Ito; Yuta Inokuchi; Hajime Yamanaka; Tomohiro Nakanishi; Takuya Hayashi; Bin Ji; Makoto Higuchi; Tetsuya Suhara; Kazuyuki Imamura; Makoto Araie; Yasuyoshi Watanabe; Hirotaka Onoe; Hideaki Hara
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

Review 6.  Imaging of the glioma microenvironment by TSPO PET.

Authors:  Bastian Zinnhardt; Federico Roncaroli; Claudia Foray; Erjon Agushi; Bahiya Osrah; Gaëlle Hugon; Andreas H Jacobs; Alexandra Winkeler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-15       Impact factor: 9.236

Review 7.  Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography.

Authors:  Laura Airas; Marjo Nylund; Eero Rissanen
Journal:  Front Neurol       Date:  2018-03-26       Impact factor: 4.003

Review 8.  Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies.

Authors:  Fabien Chauveau; Guillaume Becker; Hervé Boutin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08-13       Impact factor: 9.236

Review 9.  TSPO imaging in animal models of brain diseases.

Authors:  Nadja Van Camp; Sonia Lavisse; Pauline Roost; Francesco Gubinelli; Ansel Hillmer; Hervé Boutin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-10       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.